Cara Therapeutics: Q2 Earnings Insights

 

Cara Therapeutics CARA reported its Q2 earnings results on Monday, August 8, 2022 at 04:01 PM.

Here's what investors need to know about the announcement.

Earnings

Cara Therapeutics beat estimated earnings by 68.0%, reporting an EPS of $-0.08 versus an estimate of $-0.25.

Revenue was up $23.00 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.02 which was followed by a 23.76% increase in the share price the next day.

Here's a look at Cara Therapeutics's past performance:

 

Quarter Q1 2022 Q4 2021 Q3 2021 Q2 2021
EPS Estimate -0.54 -0.52 -0.40 -0.53
EPS Actual -0.52 -0.63 -0.02 -0.61
Revenue Estimate 3.16M 1.46M 11.21M 2.36M
Revenue Actual 4.79M 821K 20.27M 0

To track all earnings releases for Cara Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...